Medlive Technology Co., Ltd. (HKG:2192)

Medlive Technology Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	9,058	7,270	6,165	6,119	19,400	-
Market Cap Growth	17.93%	17.93%	0.75%	-68.46%	-	-
Enterprise Value	4,723	3,186	1,443	1,384	19,201	-
Last Close Price	12.36	9.80	8.10	7.95	25.31	-
PE Ratio	27.14	21.68	23.09	46.14	389.12	-
Forward PE	25.68	24.68	47.25	45.73	6.21	-
PS Ratio	15.24	12.23	13.58	17.24	55.56	-
PB Ratio	1.75	1.41	1.21	1.22	3.98	-
P/TBV Ratio	1.86	1.49	1.28	1.27	4.08	-
P/FCF Ratio	88.34	70.90	55.34	71.37	372.18	-
P/OCF Ratio	78.59	63.07	54.93	70.12	355.69	-
EV/Sales Ratio	7.95	5.36	3.18	3.90	55.00	-
EV/EBITDA Ratio	33.97	24.81	19.01	19.84	245.44	-
EV/EBIT Ratio	37.79	25.49	20.16	20.47	253.93	-
EV/FCF Ratio	46.06	31.07	12.96	16.15	368.37	-
Debt / Equity Ratio	0.01	0.01	0.00	0.00	0.00	0.08
Debt / EBITDA Ratio	0.17	0.17	0.11	0.17	0.20	0.11
Debt / FCF Ratio	0.24	0.24	0.08	0.15	0.31	0.11
Asset Turnover	0.11	0.11	0.09	0.07	0.13	1.25
Inventory Turnover	-	-	1078.32	691.56	-	-
Quick Ratio	20.89	20.89	24.04	32.74	35.42	3.23
Current Ratio	21.04	21.04	24.10	32.78	35.45	3.25
Return on Equity (ROE)	6.95%	6.95%	5.55%	3.01%	2.19%	78.29%
Return on Assets (ROA)	1.47%	1.47%	0.86%	0.86%	1.77%	37.96%
Return on Capital (ROIC)	1.54%	1.54%	0.89%	0.89%	1.86%	55.17%
Return on Capital Employed (ROCE)	2.40%	2.40%	1.40%	1.30%	1.50%	63.50%
Earnings Yield	3.70%	4.61%	4.33%	2.17%	0.26%	-
FCF Yield	1.13%	1.41%	1.81%	1.40%	0.27%	-
Dividend Yield	2.39%	2.79%	3.15%	0.93%	0.08%	-
Payout Ratio	56.81%	56.81%	51.46%	10.34%	226.51%	-
Buyback Yield / Dilution	-0.23%	-0.23%	0.26%	-15.84%	-18.82%	0.07%
Total Shareholder Return	2.16%	2.56%	3.41%	-14.91%	-18.74%	0.07%

Updated Sep 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.